loading page

Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensitivity
  • +11
  • María José Torres,
  • Axel Trautmann,
  • Ingrid Böhm,
  • Kathrin Scherer Hofmeier,
  • Annick BARBAUD,
  • Sevim Bavbek,
  • patrizia Bonadonna,
  • Josefina Cernadas,
  • Anca Chiriac,
  • Francesco Gaeta,
  • Ana Giménez Arnau,
  • Hye-Ryun Kang,
  • Esther Moreno,
  • Knut Brockow
María José Torres
Universidad de Málaga Facultad de Medicina
Author Profile
Axel Trautmann
University of Würzburg
Author Profile
Ingrid Böhm
Inselspital, University of Bern
Author Profile
Kathrin Scherer Hofmeier
University Hospital Basel
Author Profile
Sorbonne Universités, UPMC Univ Paris 06
Author Profile
Sevim Bavbek
Ankara University School of Medicine
Author Profile
patrizia Bonadonna
Integrated University Hospital of Verona
Author Profile
Josefina Cernadas
University Hospital S João, Porto , Portugal
Author Profile
Anca Chiriac
Hôpital Arnaud de Villeneuve, University Hospital of Montpellier
Author Profile
Francesco Gaeta
Columbus Hospital, Agostino Gemelli IRCCS University Hospital
Author Profile
Ana Giménez Arnau
Hospital del Mar. Institut Mar d´Investigacions Mediques
Author Profile
Hye-Ryun Kang
Seoul National University College of Medicine
Author Profile
Esther Moreno
Allergy Unit, University Hospital of Salamanca, Spain
Author Profile
Knut Brockow
Technical University of Munich
Author Profile


Immediate and non-immediate hypersensitivity reactions to iodinated contrast media (ICM) have been reported to occur in a frequency of about 0.5-3% of patients receiving non-ionic ICM. The diagnosis and management of these patients is controversial among guidelines published by various national and international scientific societies, with recommendations ranging from avoidance or premedication to drug provocation test. This position paper aims to give recommendations for the management of patients with ICM hypersensitivity reactions and analyze controversies in this area. Skin tests are recommended as the initial step for diagnosing patients with immediate and non-immediate hypersensitivity reactions; besides, they may also help guide on tolerability of alternatives. Drug provocation test is the gold-standard; although, as it is a risky procedure, the decision for performing it needs to be taken based on a risk-benefit analysis. Another source of controversy is the role of in vitro tests for diagnosis and pretreatment for preventing reactions.

Peer review status:Published

21 Jul 2020Submitted to Allergy
22 Jul 2020Submission Checks Completed
22 Jul 2020Assigned to Editor
23 Jul 2020Reviewer(s) Assigned
09 Aug 2020Review(s) Completed, Editorial Evaluation Pending
10 Aug 2020Editorial Decision: Revise Minor
15 Sep 20201st Revision Received
15 Sep 2020Assigned to Editor
15 Sep 2020Submission Checks Completed
17 Sep 2020Reviewer(s) Assigned
20 Sep 2020Review(s) Completed, Editorial Evaluation Pending
21 Sep 2020Editorial Decision: Revise Minor
30 Sep 20202nd Revision Received
30 Sep 2020Submission Checks Completed
30 Sep 2020Assigned to Editor
12 Oct 2020Reviewer(s) Assigned
12 Oct 2020Review(s) Completed, Editorial Evaluation Pending
14 Oct 2020Editorial Decision: Accept
May 2021Published in Allergy volume 76 issue 5 on pages 1325-1339. 10.1111/all.14656